SCHEMBL1126475

SCHEMBL1126475

COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(=O)[nH]c3)c3nccnc23)c1Cl.Nc1nc(CN2CCOCC2)c[nH]1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 20/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3315146 0.87 FGFR3 (0.62) FGFR3
SCHEMBL1126470 0.86 FGFR3 (0.62) FGFR3
SCHEMBL1126286 0.85 FGFR3 (0.73) FGFR3
SCHEMBL1126136 0.83 FGFR3 (1.00) FGFR3
SCHEMBL1126269 0.82 FGFR3 (1.00) FGFR3
SCHEMBL3317739 0.80 FGFR3 (0.52) FGFR3
SCHEMBL1126321 0.79 FGFR3 (0.65) FGFR3
SCHEMBL3313768 0.79 FGFR3 (0.59) FGFR3
SCHEMBL3315143 0.79 FGFR3 (0.60) FGFR3
SCHEMBL1126379 0.77 FGFR3 (0.74) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS Novartis AG (CH) 2011-02-16 EP claimed